Cardinal Health, Inc. (CAH) Tops Q4 EPS by 1c, Posts Strong FY12 Guidance
Tweet
Share
E-mailGet Alerts CAH Hot Sheet
Price: $247.18 -0.58%
Revenue Growth %: +4.2%
Financial Fact:
Interest expense, net: 44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Interest expense, net: 44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cardinal Health, Inc. (NYSE: CAH) reported Q4 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $26.8 billion versus the consensus estimate of $26.15 billion.
Cardinal Health, Inc. sees FY2012 EPS of $3.04-$3.19, versus the consensus of $3.01. Cardinal Health, Inc. sees FY2012 revenue of (n/a).
Cardinal Health, Inc. sees FY2012 EPS of $3.04-$3.19, versus the consensus of $3.01. Cardinal Health, Inc. sees FY2012 revenue of (n/a).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
